Alzheimer’s Disease

Even though newer monoclonal antibodies are available for Alzheimer’s disease, there are limits on the number of older adults who can receive them, a recent study published in Neurology finds.

Here’s how many nursing homes can meet proposed staffing requirements … Slim reimbursement for lumbar puncture an obstacle for Alzheimer’s care … Health, food policies could aid antimicrobial resistance...

Feds make deal with Regeneron on more COVID-19 monoclonal antibodies … These “secrets” help people in blue zones live longer … What it’ll take to make Alzheimer’s blood tests routine … Study...

Study: Cognition and function decline at similar rates in dementia … There are 7 things doctors can do to improve care for older adults … FDA approves Illaris for gout after failed attempts … Up...

Gene seems to protect some from Alzheimer’s, Parkinson’s … Sweating, seizure activity common day before heart attack … SSRIs can up arrhythmia risk in some people … Probiotics improve...

Headband tests brain activity for Alzheimer’s during sleep … Dementia, death risk lower with catheter ablation … Opioids up fracture risk in older adults with ankylosing spondylitis … Recognizing...

FDA gives OK to higher dose of eye disease drug … Shingles, pneumonia shots may lower Alzheimer’s risk … More findings on the Parkinson’s, gut link … Being bilingual may offer a memory perk...

An article in The BMJ is sounding the alarm that the US Food and Drug Administration fast-tracked approval for the dementia drug Rexulti (brexpiprazole) — even though trials show the drug is harmful.

COVID shots in the same arm may give better immunity … Mild cognitive impairment linked to weaker decision-making … Older women with Parkinson’s disease aren’t exercising enough … FDA approves...

People with Alzheimer’s disease have half the levels of certain antioxidants compared to people without the disease, according to a new study.